The AtCor Medical team is comprised of experienced leaders in the medical device and pharmaceutical industries.

Craig Cooper
CEO and Managing Director

Niall Cairns
Non-Executive Director

Donal O’Dwyer, BEng., MBA
Independent Non-Executive Director
Chairman of the Board, Member of the Audit & Risk Committee
and Remuneration & Nomination Committee

Donal was appointed as a Director of the AtCor Group in September 2004 and became its Chairman in November 2004. He has extensive experience in the medical devices and cardiovascular sectors, having previously been worldwide president of Cordis Cardiology, the cardiology division of Johnson & Johnson.

Other directorships include Cochlear Ltd., Mesoblast Ltd. and Fisher & Paykel Healthcare Corporation Ltd.

R. King Nelson, BA, MBA
Independent Non-Executive Director
Chairman of Remuneration & Nomination Committee, member of Audit & Risk Committee

King was elected to the Board in November 2015. He brings more than 30 years of diverse experience and expertise with medical devices. He is currently President and CEO of Uptake Medical Corporation, a company focused on treatments for emphysema and lung cancer. Previously, he served as president and CEO of Kerberos Proximal Solutions, which was acquired by FoxHollow Technologies, and as president and CEO of VenPro, a heart valve business acquired by Medtronic. Both these companies specialized in devices for the cardiovascular system. Prior to that, he spent 19 years with Baxter International and American Hospital Supply Corporation in roles of increasing responsibility that included division president for Dade Diagnostics, Bentley Labs, and Baxter’s Perfusion Services.

Craig Cooper
Chief Executive Officer

Jarrod White
Chief Financial Officer

Doug Kurschinski
Executive VP and Head of Global Sales

Lawrence Chan
Director, Product & Technology Development

Yervant Chijian
Director, Regulatory Affairs and Quality Assurance

Lindsey Schultz
Operations Manager

Ahmad Qasem
Principal Scientist